AACI Commentary

Simplifying Clinical Trials

Using Technology to Improve Operations

Read the Commentary

Register Today

2019 AACI/CCAF Annual Meeting

October 20-22, 2019
Washington, DC

Learn More

2019 Champion for Cures

The Jon M. and Karen Huntsman Family

The Jon M. and Karen Huntsman family will receive AACI's 2019 Champion for Cures Award, in recognition of their significant leadership in supporting efforts to cure cancer and in inspiring others to do the same. 
 

Learn More

2019 Distinguished Scientist

Douglas R. Lowy

Douglas R. Lowy, MD, acting director of the National Cancer Institute, will receive the 2019 AACI Distinguished Scientist Award in recognition of his scientific achievements, including his role in enabling the development of human papillomavirus (HPV) vaccines.
 

Learn More

2019 Keynote Speaker

Devon Still

Devon Still, an advocate for childhood cancer awareness and a former professional athlete, will deliver the keynote address during the 2019 AACI/CCAF Annual Meeting in Washington, DC.
 

Learn More

Register Today

2019 CAR T Symposium

The 2019 CAR T Symposium, in collaboration with the Society for Immunotherapy of Cancer (SITC), aims to identify the key challenges to patient access and delivery of CAR T, and to discuss potential solutions to address barriers to care.
 

Learn More

Take Action

Support the CLINICAL TREATMENT Act

Representatives Ben Ray Luján (D-NM) and Gus Bilirakis (R-FL) are seeking cosponsors for H.R. 913, the CLINICAL TREATMENT Act, a bill to guarantee coverage of routine care costs associated with clinical trial participation for Medicaid enrollees. 
 

Write Your Representatives

Latest News

AACI Update 
Read the August 2019 issue 

AACI Conflict of Interest Task Force
Share your comments on the recommendations 

HPV Vaccine Is Cancer Prevention
Nominate a Champion

AACI/CCAF Annual Meeting
Register today

Eliminating HPV-Related Cancers
Support the call to action

Our Mission

Working Together to Find a Cure

The Association of American Cancer Institutes (AACI) comprises 98 premier academic and freestanding cancer research centers in the U.S. and Canada. AACI is dedicated to reducing the burden of cancer by enhancing the impact of North America’s leading academic cancer centers.

CRI

Clinical
Research

Acting as a network for research leaders, AACI's Clinical Research Innovation (CRI) examines and shares best practices that promote the efficient operation of clinical research facilities.

Discover CRI
Public Policy

Public
Policy

The AACI Government Relations Forum facilitates an improved understanding of policy issues as they pertain to cancer prevention, treatment, and survivorship – for AACI members and for legislators.

Learn More
Meetings & Events

Meetings & Events

AACI events bring together cancer center leadership with national cancer research and advocacy groups, industry, and government health agencies. AACI also shares event announcements as a benefit to members. 
View All Events

Recent Headlines

Three-Day CRI Meeting Focuses on Innovation, Collaboration

Three-Day CRI Meeting Focuses on Innovation, Collaboration

Read More
BC Cancer Names New Leader

BC Cancer Names New Leader

Read More
Sylvester Comprehensive Cancer Center Earns NCI Designation

Sylvester Comprehensive Cancer Center Earns NCI Designation

Read More

Meet the President

Roy A. Jensen, MD, has been the director of The University of Kansas Cancer Center since 2004. That year, he was also appointed the William R. Jewell, M.D. Distinguished Kansas Masonic Professor, the director of the Kansas Masonic Research Institute, professor of pathology and laboratory medicine, and professor of anatomy and cell biology at the University of Kansas Medical Center. Under his leadership, KU Cancer Center earned designation as a National Cancer Institute cancer center in 2012.

With over 150 scientific publications, Dr. Jensen has lectured widely on the clinical and molecular aspects of breast cancer pathology. His research focuses on understanding the function of BRCA1 and BRCA2 and their role in breast and ovarian neoplasia; and on the characterization of premalignant breast disease.

A member of AACI's board of directors since 2013, Dr. Jensen chaired the association's 2013 program committee.

AACI Board of Directors

Presidential Initiative

For over four decades, cancer centers have worked together to lower cancer incidence and mortality rates through research and sound public policy. Such efforts can save hundreds—if not thousands—of lives over many years and represent a critical tool for lowering cancer mortality.

AACI has an unprecedented opportunity to exert enormous influence on public policy, leveraging the collective efforts of its 98 cancer centers across North America for maximum impact.

For his presidential initiative, Dr. Roy Jensen will spearhead the development of a comprehensive, cancer-specific library of model legislation and other thoroughly vetted public policy resources. 

Inspired by successful efforts at KU Cancer Center and the work of national cancer advocacy organizations, Dr. Jensen plans to launch the web-based library in 2019 to address issues ranging from state funding for cancer research to HPV vaccination, tobacco regulation, oral chemotherapy parity, and coverage of routine care for clinical trials.

Learn More